# Insilico Medicine Begins Phase III Trial of AI-Discovered Drug Rentosertib for IPF - The Clinical Trial Vanguard

*Источник: The Clinical Trial Vanguard*
*Дата: 2026-09-10*
*Язык: en*

<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxPY1dOekRQM3pObndDUVhjMWFCMG0ycl9mYlg1M1YxdC1Vb1NqbEVMaDNLSGYzT3BSRW1QQlFURkZva1ltNEh4WG91MXh5bFc5NjFOQTFpU21hTVVRTkhGUGV5R0xjRjU4aFNxaDN3czJuN1lBVlVVVWg5OGh5aEt4R05FN09sTDl6RGF0NmJxc0F3WHluamxUQ3dUR2tmc2pIZ3NBSHJZSkRDakdmN2IzT1pieFVWeU1oM1o0dFZROGlERGFZ?oc=5" target="_blank">Insilico Medicine Begins Phase III Trial of AI-Discovered Drug Rentosertib for IPF</a>&nbsp;&nbsp;<font color="#6f6f6f">The Clinical Trial Vanguard</font>

[Оригинал](https://www.clinicaltrialvanguard.com/news/insilico-medicine-begins-phase-iii-trial-of-ai-discovered-drug-rentosertib-for-ipf/)